von Knorring, Johanna
Baryshnikov, Ilya
Jylhä, Pekka
Talaslahti, Tiina
Heikkinen, Martti
Isometsä, Erkki
Funding for this research was provided by:
University of Helsinki
Article History
Received: 15 February 2023
Accepted: 21 November 2023
First Online: 28 November 2023
Declarations
:
: The Ethics Committee of Helsinki University Hospital and the Finnish Medicines Agency (FIMEA) approved the study protocol in 2018. All recruited patients gave written informed consent.
: Not applicable.
: Dr. Heikkinen has participated as a researcher in clinical trials of mood disorder pharmacotherapies sponsored by Janssen. The other authors declare that they have no conflicts of interest.